Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMD4503-1 is a quinoxaline derivative that can inhibit the interaction between LRP5/6 and sclerostin, thereby modulating the Wnt signaling pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | BMD4503-1 is a quinoxaline derivative that can inhibit the interaction between LRP5/6 and sclerostin, thereby modulating the Wnt signaling pathway. |
Molecular Weight | 433.483 |
Formula | C22H19N5O3S |
Cas No. | 301357-76-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.